US2014220626A1PendingUtilityA1
Peptide, Use of the Peptide, Method for the Production of the Peptide, Solid Support Having the Peptide Immobilized Thereon, and Method for Production of the Solid Support
Est. expiryFeb 14, 2028(~1.6 yrs left)· nominal 20-yr term from priority
C12N 11/082C07K 17/08C07K 17/02C07K 7/06C12N 11/06C07K 2319/20G01N 33/6857C07K 7/08
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided is a peptide containing a variable region and improved in production efficiency. The peptide contains a variable region to which an antigen-binding site is to be formed and has an amino acid sequence expressing a specific adsorption function to a solid phase at a site closer to the C-terminal than a heavy-chain variable region or at a site closer to the C-terminal than a light-chain variable region.
Claims
exact text as granted — not AI-modifiedWhat is claimed is as follows:
1 . A method for producing a reconstructed peptide, characterized by bringing a solution, which contains (a) a denatured peptide having an amino acid sequence expressing a specific adsorption function to a solid phase, (b) a denaturizing agent, and (c) a contaminant, into contact with a surface of the solid-phase, thereby permitting the peptide to directly adsorb to the surface of the solid phase to reconstruct a tertiary structure of the denatured peptide.
2 . The method for producing a peptide according to claim 1 , characterized in that the denatured peptide is denatured from a state of an inclusion body.
3 . The method for producing a peptide according to claim 1 , characterized in that the peptide contains a variable region in which an antigen-binding site is to be formed and has the amino acid sequence at a site closer to the C-terminal than a heavy-chain variable region or at a site closer to the C-terminal than a light-chain variable region.
4 . The method for producing a peptide according to claim 1 , characterized in that the solution contains a crushed product, a medium or a secretion of a host which produced the peptide.
5 . The method for producing a peptide according to claim 1 , characterized in that the amino acid sequence is any one of amino acid sequences represented by SEQ ID NOs: 1 to 20 of the sequence listing.
6 . The method for producing a peptide according to claim 1 , characterized in that the peptide is reconstructed a tertiary structure by the denaturing agent is removed while the peptide is directly adsorbed to the surface of the solid phase.
7 . The method for producing a peptide according to claim 1 , characterized in that the amino acid sequence expresses a specific adsorption function to a solid phase of a resin surface hydrophilically treated, the peptide is directly adsorbed to the resin surface.
8 . The method for producing a peptide according to claim 7 , characterized in that the resin surface is a hydrophilic polystyrene surface.
9 . A method for producing a solid phase having a peptide immobilized thereto, characterized by introducing a gene having a base sequence, which encodes a peptide having an amino acid sequence expressing a specific adsorption function to the solid phase, into a host to form a transformant, bringing a solution containing a product thereof into contact with a surface of the solid-phase to allow the peptide to directly adsorb to the surface of the solid-phase.
10 . The method for producing a solid phase having a peptide immobilized according to claim 9 , characterized in that the peptide contains a variable region in which an antigen-binding site is to be formed and has the amino acid sequence at a site closer to the C-terminal than a heavy-chain variable region or at a site closer to the C-terminal than a light-chain variable region.
11 . The method for producing a solid phase having a peptide immobilized according to claim 9 , characterized in that the amino acid sequence is any one of amino acid sequences represented by SEQ ID NOs: 1 to 20 of the sequence listing.
12 . A method for producing a solid phase having a peptide immobilized thereto, characterized by bringing a solution, which contains (a) a denatured peptide having an amino acid sequence expressing a specific adsorption function to a solid phase, (b) a denaturizing agent, and (c) a contaminant, into contact with a surface of the solid-phase, thereby permitting the peptide to directly adsorb to the surface of the solid phase to reconstruct a tertiary structure of the denatured peptide.
13 . The method for producing a solid phase having a peptide immobilized according to claim 12 , characterized in that the peptide contains a variable region in which an antigen-binding site is to be formed and has the amino acid sequence at a site closer to the C-terminal than a heavy-chain variable region or at a site closer to the C-terminal than a light-chain variable region.
14 . The method for producing a solid phase having a peptide immobilized according to claim 12 , characterized in that the amino acid sequence is any one of amino acid sequences represented by SEQ ID NOs: 1 to 20 of the sequence listing.
15 . The method for producing a solid phase having a peptide immobilized thereto according to claim 12 , characterized in that the solution contains a crushed product, a medium or a secretion of a host which produced the peptide.
16 . The method for producing a solid phase having a peptide immobilized according to claim 15 , characterized in that the peptide contains a variable region in which an antigen-binding site is to be formed and has the amino acid sequence at a site closer to the C-terminal than a heavy-chain variable region or at a site closer to the C-terminal than a light-chain variable region.
17 . The method for producing a solid phase having a peptide immobilized according to claim 15 , characterized in that the amino acid sequence is any one of amino acid sequences represented by SEQ ID NOs: 1 to 20 of the sequence listing.
18 . The method for producing a solid phase having a peptide immobilized thereto according to claim 9 , characterized in that the host is yeast and the solution containing the product contains a secretion produced by secretion from the yeast.
19 . The method for producing a solid phase having a peptide immobilized according to claim 18 , characterized in that the peptide contains a variable region in which an antigen-binding site is to be formed and has the amino acid sequence at a site closer to the C-terminal than a heavy-chain variable region or at a site closer to the C-terminal than a light-chain variable region.
20 . The method for producing a solid phase having a peptide immobilized according to claim 18 , characterized in that the amino acid sequence is any one of amino acid sequences represented by SEQ ID NOs: 1 to 20 of the sequence listing.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.